CareFusion Provides Update On Voluntary Recall Of EnVe® Ventilator

CareFusion CFN issued the following update regarding its previously announced voluntary recall of EnVe® ventilators. The FDA has classified this action as a Class 1 recall. The company initiated the voluntary recall in June. The products subject to the recall were manufactured between December 2010 and January 2012. This action has no effect on the manufacture or distribution of current products. In June, CareFusion sent an urgent Recall Notification to customers stating that the company had identified potential risks associated with the EnVe ventilator. A leak may occur in the patient breathing circuit or the system, resulting in the ventilator not holding the set Positive End Expiratory Pressure (PEEP) value either intermittently or continuously. The device will activate both audible and visual alarms to notify the health care professional that ventilation delivery to the patient may be compromised. A Class I recall is defined as having a reasonable probability of serious adverse health consequences or death associated with use of the defective units. Remediation plans previously announced by the company are underway and will be completed at customers' sites. To date, there have been no reports of patient harm associated with the affected devices.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!